Sandoz Strikes $500m Deal For GSK Cephalosporins

Deal To Acquire Cephalosporins Business Reinforces Position In Antibiotics

Feb 11 2021

• By David Wallace

Sandoz will pay up to $500m for the GSK cephalosporins business • Source: Shutterstock

More from Deals

More from Business